Comparative evaluation of a Medicament (Simvastatin gel) and Laser for Vital pulp therapy (pulpotomy) in primary molars
Phase 1
Completed
- Registration Number
- CTRI/2018/03/012800
- Lead Sponsor
- Centre for Dental Education and Research All india Institutte of Medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
teeth with reversible pulpitis
Exclusion Criteria
teeth with irreversible pulpitis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method teeth with no symptoms of pain,signs of abcess, sinus/fistula, no external or internal root resorptionTimepoint: at 3 months, 6 months and 12 months
- Secondary Outcome Measures
Name Time Method O Signs of Abscess, Sinus/fistula <br/ ><br>No radiographic periapical radiolucencyTimepoint: 3, 6 and 12 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways does Simvastatin gel target in primary molar pulp regeneration compared to diode laser therapy?
How does Simvastatin gel efficacy compare to formocresol in primary molar pulpotomy clinical outcomes?
Which biomarkers correlate with successful pulp healing in CTRI/2018/03/012800 trial participants?
What are the long-term adverse effects of diode laser versus Simvastatin gel in pediatric dental pulp therapy?
Are there synergistic effects of combining statin-based gels with low-level laser therapy for vital pulp treatment?